All Stories

  1. Targeted MS/MS-Based MALDI Imaging Using iprm-PASEF
  2. Systemic impact of intramuscular snake envenomation and intravenous immunoglobulin‐based antivenom treatment on murine plasma proteome and peptidome
  3. MR-SP 2 : A Microreactor-Based Workflow for Few-Cell Spatial Proteomics on the Legacy Zeiss PALM MicroBeam
  4. Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer
  5. Centrifugal microfluidic automation of the protein aggregation capture workflow for robust mass spectrometry-based proteomics
  6. Nuclear Myosin VI cooperates with actin to promote transcriptional cluster formation at androgen receptors
  7. Arp2/3-dependent regulation of ciliogenesis governs adaptive distal tubular epithelial cell states in kidney disease
  8. SDF2 and SDF2L1 are essential co-factors of DNAJB11 for Polycystin-1 processing
  9. Signatures of the systemic effects of a snake venom and antivenom: multiomics profiling of the kidney pathology
  10. A Noncatalytic Cysteine Residue Modulates Cobalamin Reactivity in the Human B12 Processing Enzyme CblC
  11. Proteomic analysis of non‐muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartment
  12. Data-Independent Acquisition: A Milestone and Prospect in Clinical Mass Spectrometry–Based Proteomics
  13. Mass Spectrometry-Based Proteomics of Poly(methylmethacrylate)-Embedded Bone
  14. Mass spectrometry‐based proteomic applications in dental implants research
  15. Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism
  16. Alternative mRNA Splicing Controls the Functions of the Histone H3K27 Demethylase UTX/KDM6A
  17. An EOMES induced epigenetic deflection initiates lineage commitment at mammalian gastrulation
  18. Neoadjuvant Chemotherapy or Combined Chemo-Radiation Therapy of Pancreatic Ductal Adenocarcinoma Differentially Shift Immune Activation, ECM Composition, Energy Metabolism, and Ribosomal Proteins of the Residual Tumor Mass
  19. Characterization of Spatial Heterogeneity in Metastasized Colorectal Cancer by MALDI Imaging
  20. Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling
  21. Proteome-Wide Identification of RNA-Dependent Proteins in Lung Cancer Cells
  22. Targeted and Explorative Profiling of Kallikrein Proteases and Global Proteome Biology of Pancreatic Ductal Adenocarcinoma, Chronic Pancreatitis, and Normal Pancreas Highlights Disease-Specific Proteome Remodelling
  23. Proteome alterations during clonal isolation of established human pancreatic cancer cell lines
  24. Addition of Chromosome 17 Polysomy and HER2 Amplification Status Improves the Accuracy of Clinicopathological Factor-Based Progression Risk Stratification and Tumor Grading of Non-Muscle-Invasive Bladder Cancer
  25. MaxQuant and MSstats in Galaxy Enable Reproducible Cloud-Based Analysis of Quantitative Proteomics Experiments for Everyone
  26. NUP133 Controls Nuclear Pore Assembly, Transcriptome Composition, and Cytoskeleton Regulation in Podocytes
  27. MaxQuant and MSstats in Galaxy enable reproducible cloud-based analysis of quantitative proteomics experiments for everyone
  28. An adapted passive model of anti-MPO dependent crescentic glomerulonephritis reveals matrix dysregulation and is amenable to modulation by CXCR4 inhibition
  29. Democratizing data-independent acquisition proteomics analysis on public cloud infrastructures via the Galaxy framework
  30. Proteome biology of primary colorectal carcinoma and corresponding liver metastases
  31. Proteome biology of primary colorectal carcinoma and corresponding liver metastases
  32. Moving translational mass spectrometry imaging towards transparent and reproducible data analyses: A case study of an urothelial cancer cohort analyzed in the Galaxy framework
  33. Democratizing Data-Independent Acquisition Proteomics Analysis on Public Cloud Infrastructures Via The Galaxy Framework
  34. A Systematic Evaluation of Semispecific Peptide Search Parameter Enables Identification of Previously Undescribed N-Terminal Peptides and Conserved Proteolytic Processing in Cancer Cell Lines
  35. EPB41L5 controls podocyte extracellular matrix assembly by adhesome-dependent force transmission
  36. Impact of DJ-1 and Helix 8 on the Proteome and Degradome of Neuron-Like Cells
  37. Origin and Expansion of the Serine Protease Repertoire in the Myelomonocyte Lineage
  38. Automation of peptide desalting for proteomic liquid chromatography – tandem mass spectrometry by centrifugal microfluidics
  39. Discovery of a novel small protein factor involved in the coordinated degradation of phycobilisomes in cyanobacteria
  40. Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell death
  41. Accessible and reproducible mass spectrometry imaging data analysis in Galaxy
  42. Targeted Metabolic Profiling of Methionine Cycle Metabolites and Redox Thiol Pools in Mammalian Plasma, Cells and Urine
  43. Impact of left ventricular assist device therapy on the cardiac proteome and metabolome composition in ischemic cardiomyopathy
  44. Neuronal-specific microexon splicing of TAF1 mRNA is directly regulated by SRRM4/nSR100
  45. A human endogenous retrovirus encoded protease potentially cleaves numerous cellular proteins
  46. Cathepsin B increases ENaC activity leading to hypertension early in nephrotic syndrome
  47. Detection and Characterization of a Mycobacterial L-Arabinofuranose ABC Transporter Identified with a Rapid Lipoproteomics Protocol
  48. Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer
  49. Accessible and reproducible mass spectrometry imaging data analysis in Galaxy
  50. Biomolecule-corona formation confers resistance of bacteria to nanoparticle-induced killing: Implications for the design of improved nanoantibiotics
  51. ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma
  52. Infection of HeLa cells with Chlamydia trachomatis inhibits protein synthesis and causes multiple changes to host cell pathways
  53. Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference
  54. FOXG1 Regulates PRKAR2B Transcriptionally and Posttranscriptionally via miR200 in the Adult Hippocampus
  55. Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance
  56. Dreidimensionale Rekonstruktion solider Tumoren
  57. Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer
  58. Multimodal imaging for radiation therapy planning in patients with primary prostate cancer
  59. Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics
  60. The two cathepsin B-like proteases of Arabidopsis thaliana are closely related enzymes with discrete endopeptidase and carboxydipeptidase activities
  61. Specificity profiling of human trypsin-isoenzymes
  62. N-Terminomics identifies HtrA1 cleavage of thrombospondin-1 with generation of a proangiogenic fragment in the polarized retinal pigment epithelial cell model of age-related macular degeneration
  63. Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin
  64. Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas
  65. Structural determinants of specificity and regulation of activity in the allosteric loop network of human KLK8/neuropsin
  66. Nanoparticle decoration impacts airborne fungal pathobiology
  67. Morphology of Immunomodulation in Breast Cancer Tumor Draining Lymph Nodes Depends on Stage and Intrinsic Subtype
  68. The pleiotropic roles of ADAM9 in the biology of solid tumors
  69. Reproducible proteomics sample preparation for single FFPE tissue slices using acid-labile surfactant and direct trypsinization
  70. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas
  71. Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node Metastases
  72. HtrA1 Mediated Intracellular Effects on Tubulin Using a Polarized RPE Disease Model
  73. The WD40-domain containing protein CORO2B is specifically enriched in glomerular podocytes and regulates the ventral actin cytoskeleton
  74. HtrA1 activation is driven by an allosteric mechanism of inter-monomer communication
  75. OpenMS – A platform for reproducible analysis of mass spectrometry data
  76. Proteome profiling of clear cell renal cell carcinoma in von Hippel-Lindau patients highlights upregulation of Xaa-Pro aminopeptidase-1, an anti-proliferative and anti-migratory exoprotease
  77. Differential effect of TGFβ on the proteome of cancer associated fibroblasts and cancer epithelial cells in a co-culture approach - a short report
  78. Determinants of Macromolecular Specificity from Proteomics-De rived Peptide Substrate Data
  79. Form follows function: Morphological and immunohistological insights into epithelial–mesenchymal transition characteristics of tumor buds
  80. The papain-like cysteine proteinases NbCysP6 and NbCysP7 are highly processive enzymes with substrate specificities complementary to Nicotiana benthamiana cathepsin B
  81. Proteomics highlights decrease of matricellular proteins in left ventricular assist device therapy†
  82. Identification of Protease Cleavage Sites by Charge-Based Enrichment of Protein N-Termini
  83. Profiling of Protease Cleavage Sites by Proteome-Derived Peptide Libraries and Quantitative Proteomics
  84. Proteomic analysis of lung metastases in a murine breast cancer model reveals divergent influence of CTSB and CTSL overexpression
  85. System-Wide Profiling of Protein Amino Termini from Formalin-Fixed, Paraffin-Embedded Tissue Specimens for the Identification of Novel Substrates
  86. The Prognostic Impact of the Carcinoembryonic Antigen in Ampullary Cancer - A Retrospective Single Center Study
  87. Tenascin-C Orchestrates Glioblastoma Angiogenesis by Modulation of Pro- and Anti-angiogenic Signaling
  88. Proteomic analysis of silenced cathepsin B expression suggests non-proteolytic cathepsin B functionality
  89. Yeast membrane proteomics using leucine metabolic labelling: Bioinformatic data processing and exemplary application to the ER-intramembrane protease Ypf1
  90. OpenMS: a flexible open-source software platform for mass spectrometry data analysis
  91. The death enzyme CP14 is a unique papain-like cysteine proteinase with a pronounced S2 subsite selectivity
  92. Proteomic Profiling of Cardiomyocyte-Specific Cathepsin A Overexpression Links Cathepsin A to the Oxidative Stress Response
  93. Comprehensive Proteomic Analysis of Nitrogen-Starved Mycobacterium smegmatis Δpup Reveals the Impact of Pupylation on Nitrogen Stress Response
  94. Active site specificity profiling datasets of matrix metalloproteinases (MMPs) 1, 2, 3, 7, 8, 9, 12, 13 and 14
  95. Cathepsin A inhibition attenuates myocardial infarction-induced heart failure on the functional and proteomic levels
  96. Identification of Protease Specificity by Combining Proteome-Derived Peptide Libraries and Quantitative Proteomics
  97. Skin Barrier Defects Caused by Keratinocyte-Specific Deletion of ADAM17 or EGFR Are Based on Highly Similar Proteome and Degradome Alterations
  98. Formalin-Fixed, Paraffin-Embedded Tissues (FFPE) as a Robust Source for the Profiling of Native and Protease-Generated Protein Amino Termini
  99. Characterization of various cell lines from different ampullary cancer subtypes and cancer associated fibroblast-mediated responses
  100. Impact of cathepsin B on the interstitial fluid proteome of murine breast cancers
  101. Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses
  102. Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters
  103. Pregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall Survival
  104. Taspase1: a 'misunderstood' protease with translational cancer relevance
  105. A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity
  106. An Aminopeptidase in the Drosophila Testicular Niche Acts in Germline Stem Cell Maintenance and Spermatogonial Dedifferentiation
  107. The stromal cell-surface protease fibroblast activation protein-α localizes to lipid rafts and is recruited to invadopodia
  108. Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations
  109. Quantitative proteomic analysis of formalin–fixed, paraffin–embedded clear cell renal cell carcinoma tissue using stable isotopic dimethylation of primary amines
  110. Toward improved peptide feature detection in quantitative proteomics using stable isotope labeling
  111. miR-200c dampens cancer cell migration via regulation of protein kinase A subunits
  112. Enrichment of protein N-termini by charge reversal of internal peptides
  113. The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells
  114. The emerging role of the peptidome in biomarker discovery and degradome profiling
  115. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma
  116. Protein amino-terminal modifications and proteomic approaches for N-terminal profiling
  117. Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells
  118. Evolutionary divergence of Threonine Aspartase1 leads to species-specific substrate recognition
  119. The Yeast ER-Intramembrane Protease Ypf1 Refines Nutrient Sensing by Regulating Transporter Abundance
  120. Carboxyterminal Protein Processing in Health and Disease: Key Actors and Emerging Technologies
  121. Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface
  122. Septins Arrange F-Actin-Containing Fibers on the Chlamydia trachomatis Inclusion and Are Required for Normal Release of the Inclusion by Extrusion
  123. Impact of routinely employed procedures for tissue processing on the proteomic analysis of formalin-fixed paraffin-embedded tissue
  124. Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer
  125. Proteases and Disease
  126. Global remodelling of cellular microenvironment due to loss of collagen VII
  127. Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy
  128. Transmembrane Collagen XVII Modulates Integrin Dependent Keratinocyte Migration via PI3K/Rac1 Signaling
  129. Automated peptide mapping and protein-topographical annotation of proteomics data
  130. Proteomic identification of protease cleavage sites: cell-biological and biomedical applications
  131. Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells
  132. Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis
  133. Glycocapture-based proteomics for secretome analysis
  134. Limited and Degradative Proteolysis in the Context of Posttranslational Regulatory Networks: Current Technical and Conceptional Advances
  135. Deletion of Cysteine Cathepsins B or L Yields Differential Impacts on Murine Skin Proteome and Degradome
  136. Enhanced identification of peptides lacking basic residues by LC-ESI-MS/MS analysis of singly charged peptides
  137. NSP4, an elastase-related protease in human neutrophils with arginine specificity
  138. Proteomic Identification of Protease Cleavage Sites Characterizes Prime and Non-prime Specificity of Cysteine Cathepsins B, L, and S
  139. Correction to Proteomic Identification of Protease Cleavage Sites Characterizes Prime and Non-prime Specificity of Cysteine Cathepsins B, L, and S
  140. Factor Xa subsite mapping by proteome-derived peptide libraries improved using WebPICS, a resource for proteomic identification of cleavage sites
  141. Contribution of cathepsin L to secretome composition and cleavage pattern of mouse embryonic fibroblasts
  142. Contribution of cathepsin L to secretome composition and cleavage pattern of mouse embryonic fibroblasts
  143. Proteomic Analyses Reveal an Acidic Prime Side Specificity for the Astacin Metalloprotease Family Reflected by Physiological Substrates
  144. Metalloprotease Meprin β Generates Nontoxic N-terminal Amyloid Precursor Protein Fragmentsin Vivo
  145. Protease Specificity Profiling by Tandem Mass Spectrometry Using Proteome-Derived Peptide Libraries
  146. Identification and Relative Quantification of Native and Proteolytically Generated Protein C-Termini from Complex Proteomes: C-Terminome Analysis
  147. Characterization of the prime and non-prime active site specificities of proteases by proteome-derived peptide libraries and tandem mass spectrometry
  148. Biological role of matrix metalloproteinases: a critical balance
  149. Proteomic techniques and activity-based probes for the system-wide study of proteolysis
  150. Proteome-wide analysis of protein carboxy termini: C terminomics
  151. Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products
  152. Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites
  153. Protease subsite profiling with proteome-derived peptide libraries (PICS)
  154. Metal Requirements and Phosphodiesterase Activity of tRNase Z Enzymes †
  155. Proteomic discovery of protease substrates
  156. The Crystal Structure of the Zinc Phosphodiesterase from Escherichia coli Provides Insight into Function and Cooperativity of tRNase Z-Family Proteins
  157. Exosite Modules Guide Substrate Recognition in the ZiPD/ElaC Protein Family
  158. Erratum to “Characterization of an Escherichia coli elaC deletion mutant” [Biochem. Biophys. Res. Commun. 320 (2004) 1365–1373]
  159. The tRNase Z family of proteins: physiological functions, substrate specificity and structural properties
  160. Zinc- and iron-dependent cytosolic metallo-β-lactamase domain proteins exhibit similar zinc-binding affinities, independent of an atypical glutamate at the metal-binding site
  161. Functional diversity and metal selectivity of proteins sharing the metallo-β-lactamase fold
  162. Characterization of an Escherichia coli elaC deletion mutant
  163. Identification of Metal Binding Residues for the Binuclear Zinc Phosphodiesterase Reveals Identical Coordination as Glyoxalase II
  164. The binding of iron and zinc to glyoxalase II occurs exclusively as di-metal centers and is unique within the metallo-β-lactamase family
  165. Flexible Metal Binding of the Metallo-β-lactamase Domain:  Glyoxalase II Incorporates Iron, Manganese, and Zinc in Vivo †
  166. Activation Mechanism of Pro-astacin: Role of the Pro-peptide, Tryptic and Autoproteolytic Cleavage and Importance of Precise Amino-terminal Processing
  167. The GCM domain is a Zn-coordinating DNA-binding domain
  168. ElaCEncodes a Novel Binuclear Zinc Phosphodiesterase